OncoMed Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference
[GlobeNewswire] – REDWOOD CITY, Calif. — OncoMed Pharmaceuticals, Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that Paul … moreView todays social media effects on OMEDView the latest stocks trending across Twitter. Click to view dashboardSee who OncoMed is hiring next, click here to view […]